This content is only available within our institutional offering.
18 Oct 2017
PANMURE: PG:GP – Issue 5
Advanced Medical Solutions Group plc (AMS:LON), 217 | Allergy Therapeutics plc (AGY:LON), 10.5 | Animalcare Group PLC (ANCR:LON), 280 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 24.8 | Faron Pharmaceuticals Oy (FARN:LON), 55.5 | ImmuPharma plc (IMM:LON), 6.5 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 12.5 | Venture Life Group Plc (VLG:LON), 70.5 | HUTCHMED (China) Limited (HCM:LON), 214 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0 | MaxCyte, Inc. (MYE0:FRA), 0
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: PG:GP – Issue 5
Advanced Medical Solutions Group plc (AMS:LON), 217 | Allergy Therapeutics plc (AGY:LON), 10.5 | Animalcare Group PLC (ANCR:LON), 280 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 24.8 | Faron Pharmaceuticals Oy (FARN:LON), 55.5 | ImmuPharma plc (IMM:LON), 6.5 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 12.5 | Venture Life Group Plc (VLG:LON), 70.5 | HUTCHMED (China) Limited (HCM:LON), 214 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0 | MaxCyte, Inc. (MYE0:FRA), 0
- Published:
18 Oct 2017 -
Author:
Julie Simmonds -
Pages:
29 -